[11C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trialXilin Wu, Morris J. Brown, Victoria Warnes et al.|Nature Medicine|2023Cited by 137
Molecular Imaging Versus Adrenal Vein Sampling for the Detection of Surgically Curable Primary AldosteronismEmily Goodchild, Morris J. Brown, Xilin Wu et al.|Annals of Internal Medicine|2025Cited by 26
Endoscopic, ultrasound-guided, radiofrequency ablation of aldosterone-producing adenomas (FABULAS): a UK, multicentre, prospective, proof-of-concept trialGiulia Argentesi, Xi‐Lin Wu, Alexander Ney et al.|The Lancet|2025Cited by 25
THU594 Outcome Data From Fabulas: A Feasibility Study Of Radiofrequency Endoscopic Ablation, With Ultrasound Guidance, As A Non-surgical, Adrenal Sparing Treatment For Aldosterone Producing AdenomasGiulia Argentesi, Morris J. Brown, Xilin Wu et al.|Journal of the Endocrine Society|2023Cited by 1
Novel radiolabeled ligand, Para-chloro-2-[<sup>18</sup>F]fluoroethyletomidate (CETO) compared to [<sup>11</sup>C]metomidate-PET (MTO) for the lateralisation of primary aldosteronism (PA)Emily Goodchild, Morris J. Brown, Russell Senanayake et al.|Endocrine Abstracts|2022Cited by 1